SCHEMBL37644

SCHEMBL37644

O=c1[nH]c(Cc2ccc(Cl)c(Cl)c2)nc2cc(S(=O)(=O)O)sc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 3/20 0.53
RNASEH1 O60930 1/20 0.50
RAB9A P51151 3/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TYMP P19971 1/20 0.39
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
ALOX12 P18054 1/20 0.37
PNP P00491 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
PKM P14618 1/20 0.36
KMT2A Q03164 1/20 0.36
TYMS P04818 1/20 0.35
CCNE1 P24864 2/20 0.35
CDK2 P24941 2/20 0.35
CDC7 O00311 1/20 0.35
ROCK1 Q13464 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38381 0.89 PDE5A (0.47) PDE5ARNASEH1RAB9ALMNAKDM4E
SCHEMBL38312 0.87 PDE5A (0.70) PDE5ARAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL38180 0.79 PDE5A (0.60) PDE5ARNASEH1RAB9ALMNAKDM4E
SCHEMBL37584 0.77 PDE5A (0.66) PDE5ARAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL38977 0.77 RNASEH1 (0.49) PDE5ARNASEH1RAB9ALMNAKDM4E
SCHEMBL38484 0.77 PDE5A (0.57) PDE5ARNASEH1RAB9ALMNAKDM4E
SCHEMBL46456 0.77 PDE5A (0.57) PDE5ARNASEH1RAB9ALMNAKDM4E
SCHEMBL38179 0.76 PDE5A (0.46) PDE5ARNASEH1RAB9ALMNAKDM4E
SCHEMBL38035 0.75 PDE5A (0.55) PDE5ARNASEH1RAB9ALMNAKDM4E
SCHEMBL37998 0.75 RNASEH1 (0.49) PDE5ARNASEH1RAB9ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012004900-A1 THIENOPYRIMIDINE COMPOUNDS ASKA PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 WO disclosed